RSAD2 and lip and oral cavity carcinoma: The Cancer Genome Atlas (TCGA) gene expression profile and Kaplan–Meier analysis revealed that high expression of radical s‐adenosyl methionine domain containing 2 (RSAD2) in patients with oral cancer was associated with a better prognosis.48